Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Description | Exelon 13.3mg/24hours transdermal patches (Novartis Pharmaceuticals UK Ltd) |
| BNF code | 0411000E0BBAHAI |
| Virtual Medicinal Product | Rivastigmine 13.3mg/24hours transdermal patches |
| Name | Exelon 13.3mg/24hours transdermal patches |
| Date of name applicability | 13 Feb 2014 |
| Previous name | Exelon 13.3 mg/24hours transdermal patches |
| Supplier | Novartis Pharmaceuticals UK Ltd |
| Current licensing authority | Medicines - MHRA/EMA |
| EMA additional monitoring | ✗ |
| Parallel import | ✗ |
| Restrictions on availability | None |
| Licensed Route | |
|---|---|
| Licenced route | Transdermal |
| Actual Medicinal Product Packs | |
| Exelon 13.3mg/24hours transdermal patches (Novartis Pharmaceuticals UK Ltd) 30 patch | |
dm+d data retrieved from TRUD: release NHSBSA_11.2.0_20241118000001, imported on 19th November 2024 at 03:53:26.